Pre-Market Surge in Vaccine Stocks Due to Rise in Flu Cases

Investing.com -- As seasonal flu cases rise nationwide, vaccine manufacturers continue to see gains in pre-market trading. Two vaccine developers, Moderna and Novavax, made progress in the pre-market session, with Moderna up 4.9% and Novavax rising 6.7%. Other vaccine stocks to watch include CureVac, BioNTech (NASDAQ:BNTX), and Pfizer. In addition to vaccine developers, pharmacy chains and hospital companies are also on the watch list, including Walgreens, CVS Health, and HCA Healthcare. As the flu season progresses, changes in the stock performance of these companies may be observed.